This inventor holds 1 USPTO granted patent. Top assignee: Cardiopharma, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: David P Hause: Innovator in Cardiovascular Pharmaceuticals
Introduction
David P Hause is a notable inventor based in Carrboro, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cardiovascular medications. His innovative approach has led to the creation of a unique fixed-dose combination that addresses both hypertension and cholesterol levels.
Latest Patents
David P Hause holds a patent for an "Anti-hypertensive and cholesterol-lowering fixed-dose combination and method of manufacture." This patent discloses a method for manufacturing a cardiovascular fixed-dose combination pharmaceutical dosage form that includes an anti-hypertensive active agent and a cholesterol-lowering active agent. The formulation is designed to enhance the aqueous solubility of the cholesterol-lowering agent while being free of citric acid. This ensures that the active agents maintain the same strength and release profiles as when prepared as a single formulation.
Career Highlights
David P Hause is associated with Cardiopharma, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in drug formulation and manufacturing processes has positioned him as a valuable asset in the field.
Collaborations
Throughout his career, David has collaborated with notable professionals, including Roy A Stimits and Daniel Tyree Gregory, Jr. These collaborations have further enhanced his work and contributed to the advancement of cardiovascular treatments.
Conclusion
David P Hause's contributions to the pharmaceutical industry, particularly in cardiovascular health, highlight his innovative spirit and dedication to improving patient outcomes. His work continues to influence the development of effective medications for managing hypertension and cholesterol levels.